Literature DB >> 21350831

Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia.

Jean-Valère Malfuson, Johanna Konopacki, Thierry Fagot, François Desangles, Dominique Bories, Bertrand Souleau, Thierry de Revel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21350831     DOI： 10.1007/s00277-011-1188-1

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  Marked response to imatinib mesylate in a patient with platelet-derived growth factor receptor beta-associated acute myeloid leukemia.

Authors:  Yoshimitsu Shimomura; Hayato Maruoka; Takayuki Ishikawa
Journal:  Int J Hematol       Date:  2016-12-20       Impact factor: 2.490

2.  TRIP11-PDGFRB fusion in a patient with a therapy-related myeloid neoplasm with t(5;14)(q33;q32) after treatment for acute promyelocytic leukemia.

Authors:  Hoon-Gu Kim; Ja-Hyun Jang; Eun-Ha Koh
Journal:  Mol Cytogenet       Date:  2014-12-23       Impact factor: 2.009
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.